P2.04-88 Surgical Outcomes of a Multicenter Phase II Trial of Neoadjuvant Atezolizumab in Resectable Stages IB-IIIB NSCLC: Update on LCMC3 Clinical Trial

J. Lee,J. Chaft,A. Nicholas, G. Patterson,S. Waqar, E. Toloza,E. Haura, D. Raz, K. Reckamp,R. Merritt,D. Owen,D. Finley, C. Mcnamee,J. Blasberg,E. Garon,J. Mitchell,R. Doebele, F. Baciewicz,M. Nagasaka,H. Pass

JOURNAL OF THORACIC ONCOLOGY(2019)

引用 10|浏览102
暂无评分
关键词
neoadjuvant,immuno-oncology,early stage lung cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要